The Tides Asia conference features a robust program that includes exhibitions showcasing innovative products, research findings, and technologies. Attendees can expect a variety of seminars and keynote presentations that highlight emerging trends in the industry. Networking opportunities are abundant, allowing participants to connect with industry leaders, researchers, and potential collaborators. The event aims to facilitate discussions on the challenges and opportunities within the therapeutic landscape, fostering a collaborative environment to stimulate advancements within the sector.
In terms of audience, Tides Asia attracts a diverse group of stakeholders from the healthcare industry, including pharmaceutical companies, biotech firms, academic institutions, and research organizations. Professionals ranging from scientists and researchers to executives and regulatory affairs specialists will find valuable insights and opportunities tailored to their interests.
Event Details and Location
– Event Name: Tides Asia: Oligonucleotide and Peptide Therapeutics
– Event Start Date: February 24, 2026
– Event End Date: February 26, 2026
– Venue Name: Westin Miyako Kyōto
– Venue Address: 〒1 Kyōto, Higashiyama Ward, Awadaguchi Kachōchō, JP 605-0052, Keage Sanjo, Higashiyaman-Ku
– City: Awadaguchi Kachōchō
– Country: Japan
– Website: Tides Asia
Major themes at Tides Asia will revolve around the latest scientific research in oligonucleotide and peptide therapeutics, regulatory developments, and innovative methods in drug formulation and delivery systems. Topics covering industry standards, patient-centric approaches in development, and collaborations between academia and industry are expected to be prominently featured.
In conclusion, Tides Asia: Oligonucleotide and Peptide Therapeutics stands out as a significant event within the healthcare sector, particularly for professionals involved in therapeutic innovation. Its focus on cutting-edge research and strategic networking makes it an essential destination for those aiming to remain at the forefront of developments in oligonucleotide and peptide therapies.
Categories / Tags / Industries:
– Healthcare
– Pharmaceuticals
– Biotech
– Oligonucleotides
– Peptides
– Therapeutics
– Research
– Networking
– Innovation
